Geneflux Biosciences is a multidimensional diagnostic company focussed towards providing specialized, high-end confirmatory & predictive tests to a robust customer base comprising of all major tertiary hospitals, medical centres and community health care providers in Malaysia. Established in the year 2007, Geneflux now has subsidiaries and branch offices in the UK (London), USA (Detroit) and India (Bangalore). Headquartered in Puchong, Selangor in our state of the art molecular diagnostic laboratory, Geneflux has been at the forefront of the fast-evolving diagnostic spectrum in Malaysia.
Geneflux® Biosciences is a privately held, research and technology driven Biotechnology Company specialized in the manufacture of molecular diagnostic kits and providing services to government and private hospitals in Malaysia. We are a “BioNexus Status” (2008) company.
WHO WE ARE
More About Geneflux Bioscience
Geneflux® was established in the year 2007 in Malaysia with registered offices in India, UK and USA.
We are focused on “polymerase chain reaction (PCR)” and “next generation sequencing” (NGS) technologies. Our flagship product, MyDENKit (Acronym for Malaysian Dengue Kit) received the decorated ‘Excellence award” from the Ministry of Science, Technology and Innovation (MOSTI) in 2009. We have got a very well equipped biotechnology laboratory, which has capability to manufacture hundred kits and analyze thousands of clinical specimens every day. We are also the recipient of Frost & Sullivan awards namely, “2010 Asia Pacific Niche Company of the Year Award in Molecular Diagnostics” and “2012 South East Asian Fastest Growing Company in Molecular Diagnostics for Infectious Diseases”. In 2013, the “Biotechnology Excellence Award” was given to Geneflux® by MOSTI, Malaysia and “Bio Medical Excellence Award 2013” from Biotech Corp.